Mastek reschedules Sept 1 investor meet to 2:15 pm with Anand Rathi
- Mastek holds single investor meet on September 1, 2026
- Interaction scheduled for 2:15 pm in Mumbai
- Partner is Anand Rathi Share and Stock Brokers Ltd.
- No UPSI to be shared during the one-to-one session

*this image is generated using AI for illustrative purposes only.
Mastek has updated the schedule for its upcoming investor meeting on September 1, 2026. The company will now hold a single investor interaction with Anand Rathi Share and Stock Brokers Ltd. at 2:15 pm in Mumbai, replacing the previously announced group dialogue.
Revised meet details
The earlier announcement indicated that Mastek would participate in the Ashwamedh - Elara India Dialogue 2026 as part of a group investor meet starting at 9:00 am. The new filing clarifies that the engagement is now a one-to-one interaction scheduled for the afternoon slot.
| Parameter | Previous Details | Updated Details |
|---|---|---|
| Date | September 1, 2026 | September 1, 2026 |
| Counterparty | Ashwamedh - Elara India Dialogue | Anand Rathi Share and Stock Brokers Ltd. |
| Nature of meet | Group Investor Meet | Single Investor Meet |
| Timing | 9:00 am | 2:15 pm |
| Venue/Mode | Mumbai / In-Person | Mumbai / In-Person |
Compliance and disclosure
The interaction is governed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mastek has confirmed that discussions will be based on publicly available information regarding industry and company-specific developments. No unpublished price sensitive information (UPSI) is proposed to be shared during the meet. The intimation was filed on August 31, 2026, and hosted on the company's website.
Historical Stock Returns for Mastek
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.18% | +0.41% | -11.03% | +10.80% | -34.78% | -46.44% |
How might the shift from a group dialogue to a one-to-one meeting with Anand Rathi influence the depth and specificity of insights shared regarding Mastek's strategic roadmap?
What does the change in counterparty suggest about Mastek's current investor relations strategy or targeted market segments for 2026?
Could this scheduling adjustment indicate any internal operational changes or shifts in management availability that investors should monitor?


































